Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Skye Bioscience, Inc. (SKYE) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-12.51M |
|
-- |
|
-- |
|
$12.67M |
|
$-12.67M |
|
$0.17M |
|
$-12.51M |
|
$-12.51M |
|
$-12.51M |
|
$-12.51M |
|
$-12.51M |
|
$-12.51M |
|
$-12.67M |
|
$-12.50M |
|
39.68M |
|
39.68M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$18.57M |
|
$0.76M |
|
$0.85M |
|
$19.42M |
|
$10.40M |
|
-- |
|
-- |
|
$10.40M |
|
$9.01M |
|
$9.01M |
|
$9.01M |
|
35.13M |
|
| Cash Flow Statement Financials | |
$-8.56M |
|
$10.90M |
|
$-0.07M |
|
$5.88M |
|
$8.15M |
|
$2.27M |
|
$1.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.78 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-138.81% |
|
-138.81% |
|
-64.43% |
|
-138.81% |
|
$0.26 |
|
$-0.22 |
|
$-0.22 |
|